In addition, NKX2-1 is aberrantly activated in diffuse large B-cell lymphoma (DLBCL) where it is deregulated by an altered chromatin configuration instead of a chromosomal rearrangement [63]. The gene discussed is NKX2-1; the disease is diffuse large B-cell lymphoma.